A Comprehensive Course on SGLT2 Inhibitors: An Update

Type 2 Diabetes is that chronic condition which can create complications for any other morbidity. RSSDI is conducting an updated comprehensive course on SGLT2 inhibitors. The evolution of these antidiabetic drugs, their positioning, benefits and possible threats in daily practice will be of prime focus in the curriculum. The CME session will also shed light on guideline recommendations in clinical practice. Practicing diabetologists will benefit out of the case-based approach in the modules.